Thank you to all those who were able to attend the 2022 QCGC Research Patient & Community Symposium recently, either in-person or remotely. If you would like to view any of the presentations again or if you were unable to make the event, the recording is now available. We sincerely thank our guest speakers for providing valuable information and updates on their area of expertise. We are grateful to to City Hall and Epicure for their professional AV expertise. Sincere thanks to our event sponsor AstraZeneca for their ongoing support.

Watch the full presentation here. Below is the presentation timing breakdown to help you move easily to a particular topic.

Presentation timing breakdown:

(6min 57sec) Welcome and Symposium Open - Lisa Harrold

(8min 46sec) Reversal of medicine and its impact on patients - Prof Andreas Obermair, Director of Research, QCGC, UQ; & Prof Pedro Ramirez Director of Minimally Invasive Surgical Research & Education, The University of Texas MD Anderson Cancer Center.

(9mins, 7sec)  Part 1 - Prof. Obermair - what does it mean "evidence to inform clinical management"

(16mins, 0sec)  Part 2 - Prof. Ramirez - reversal of medicine phenomenon

(30mins, 55sec)  Part 3 - Prof. Obermair - how patients benefit

(43min, 44sec) Genetic link between endometriosis and ovarian cancer - Dr Sally Mortlock Research Fellow; Institute for Molecular Bioscience, UQ.

(1hr, 3min, 7sec) Is assisted reproduction a risk factor for gynaecological cancer? Can young women diagnosed with ovarian cancer preserve their fertility? - Dr Matthew Smith Obstetrician, Gynaecologist, Fertility Specialist.

(1hr 55min 33sec) Cherish Challenge 2023 Launch - Climb Kilimanjaro, Kathleen Banks, Cherish Women's Cancer Foundation

(2hr, 0min, 9sec) Vulvar Cancer project - Prof Andreas Obermair Director of Research, Director of Research, QCGC, UQ;

(2hr, 20min, 10sec) International gynaecological cancer research projects that we should all know about - Dr Kristen Moloney Gynaecological Oncologist, Royal Brisbane & Women's Hospital (1hr, 3min, 07sec)

(2hr, 50min, 22sec) feMMe Molecular project - Dr Eva Baxter, Postdoctoral Research Fellow, QCGC Research, UQ & Dr Michelle Alizart Pathology Queensland, Royal Brisbane & Women's Hospital (1hr, 3min, 07sec)

(9mins, 7sec)  Part 1 - Dr Eva Baxter - feMMe Molecular update

(16mins, 0sec)  Part 2 - Dr Michelle Alizart - A pathologist's perspective

(3hr, 17min, 14sec) Thank you and symposium close - Lisa Harrold

Register now to secure your seat at the 2022 QCGC Research Patient & Community Symposium - Saturday 15 October, 9am to 12noon in the Sherwood Room at Brisbane City Hall, 64 Adelaide Street, Brisbane City. To register to attend click here.

This face-to-face event will satisfy the information needs and curiosity of gynaecological cancer patients & survivors, families and friends of patients and everyone who is interested in the topic. We present a line-up of amazing presenters and experts in their respective fields to inform you about “hot topics” in gynaecological cancer.  We will also live-stream the Symposium for those that can’t be there in person and would like to join us remotely. To register to watch the event live streamed, via remote access click here.

Don't miss this one! Please refer to the program below for details. For further information or assistance with registration, please email or call 07 3346 5031. Sincere thanks to our event sponsor AstraZeneca for their ongoing support.